MRVL:NASDAQMarvell Technology, Inc. Analysis
Data as of 2026-09-09 - not real-time
$235.01
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Marvell Technology, Inc. trades at $235.01, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. Across the trailing 30 sessions it gained 34.7%. Relative strength is 55.5 — neutral — and the MACD signal is bearish. Recent trading has carved out support near $200.62 and resistance around $254.60.
Multiples put this in overvalued territory: 77.8 times earnings against the sector's 33.3. Analyst price targets sit 21.3% above the current price. Revenue is growing at 36.5% on a 27.9% profit margin. The 0.11% dividend yield looks covered by current payout levels.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 85.9%, a beta of 2.97 and a maximum drawdown of 48.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.
Multiples put this in overvalued territory: 77.8 times earnings against the sector's 33.3. Analyst price targets sit 21.3% above the current price. Revenue is growing at 36.5% on a 27.9% profit margin. The 0.11% dividend yield looks covered by current payout levels.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 85.9%, a beta of 2.97 and a maximum drawdown of 48.4%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.
Top Market Events
Marvell Technology, Inc. NASDAQ:MRVL has expanded its partnership with Google to develop custom chips for AI...<?xml encoding="utf-8" ? Marvell Technology Inc. MRVL stock edged higher Wednesday in premarket trading as...Seeking Alpha14dMarvell preview: AI networking, custom silicon in focusMarvell Technology MRVL will report...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 153.27
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 77.8 versus sector average of 33.3
- Trading above the 200-day average of 153.27
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 77.8 versus sector average of 33.3
- Analyst targets imply +21.3% versus the current price
- Profit margin of 27.9% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth36.50%
Profit Margin27.93%
P/E Ratio77.8
ROE16.52%
ROA4.13%
Debt/Equity28.52
P/B Ratio11.3
Op. Cash Flow$2.2B
Free Cash Flow$2.4B
Industry P/E33.3
Technical Analysis
TrendBullish
RSI55.5
Support$200.62
Resistance$254.60
MA 20$226.56
MA 50$218.98
MA 200$153.27
MACDBearish
VolumeStable
Fear & Greed Index92.04
Valuation
Fair Value$90.54
Target Price$285.00
Upside/Downside21.27%
GradeOvervalued
TypeGrowth
Dividend Yield0.11%
Risk Assessment
Beta2.97
Volatility85.94%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.